OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester, Jacques‐Eric Gottenberg, Roberto Caporali, et al.
Annals of the Rheumatic Diseases (2024), pp. ard-225759
Open Access | Times Cited: 7
Gerd R Burmester, Jacques‐Eric Gottenberg, Roberto Caporali, et al.
Annals of the Rheumatic Diseases (2024), pp. ard-225759
Open Access | Times Cited: 7
Showing 7 citing articles:
Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study
René Westhovens, Kevin Winthrop, Arthur Kavanaugh, et al.
RMD Open (2025) Vol. 11, Iss. 1, pp. e004857-e004857
Open Access
René Westhovens, Kevin Winthrop, Arthur Kavanaugh, et al.
RMD Open (2025) Vol. 11, Iss. 1, pp. e004857-e004857
Open Access
Safety of Janus kinase inhibitors in immune-mediated inflammatory diseases—a systematic literature review informing the 2024 update of an international expert consensus statement
Victoria Konzett, Josef S Smolen, Peter Nash, et al.
Annals of the Rheumatic Diseases (2025)
Open Access
Victoria Konzett, Josef S Smolen, Peter Nash, et al.
Annals of the Rheumatic Diseases (2025)
Open Access
Major adverse cardiovascular, thromboembolic and malignancy events in the filgotinib rheumatoid arthritis and ulcerative colitis clinical development programmes
Xavier Mariette, Sven Borchmann, Sandrine Aspeslagh, et al.
RMD Open (2025) Vol. 11, Iss. 1, pp. e005033-e005033
Open Access
Xavier Mariette, Sven Borchmann, Sandrine Aspeslagh, et al.
RMD Open (2025) Vol. 11, Iss. 1, pp. e005033-e005033
Open Access
Long‐term safety and efficacy of filgotinib for the treatment of moderately to severely active ulcerative colitis: Interim analysis from up to 4 years of follow‐up in the SELECTION open‐label long‐term extension study
Brian G. Feagan, Katsuyoshi Matsuoka, Gerhard Rogler, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 5, pp. 563-584
Open Access | Times Cited: 2
Brian G. Feagan, Katsuyoshi Matsuoka, Gerhard Rogler, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 5, pp. 563-584
Open Access | Times Cited: 2
Efficacy and Safety of Janus Kinase-Inhibitors in Ulcerative Colitis
Benedetto Neri, Roberto Mancone, Mariasofia Fiorillo, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7186-7186
Open Access | Times Cited: 2
Benedetto Neri, Roberto Mancone, Mariasofia Fiorillo, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7186-7186
Open Access | Times Cited: 2
Efficacy and Safety of Filgotinib in Rheumatoid Arthritis Patients Aged over and under 65 Years (ENANTIA-65)
Maurizio Benucci, Marco Bardelli, Massimiliano Cazzato, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 7, pp. 712-712
Open Access
Maurizio Benucci, Marco Bardelli, Massimiliano Cazzato, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 7, pp. 712-712
Open Access
LATE-ONSET RHEUMATOID ARTHRITIS TREATED WITH BARICITINIB AND LEFLUNOMIDE- A CASE REPORT
Tatjana Zekić, Nadica Laktašić-Žerjavić
Anti-Aging Eastern Europe (2024) Vol. 3, Iss. 4, pp. 241-245
Open Access
Tatjana Zekić, Nadica Laktašić-Žerjavić
Anti-Aging Eastern Europe (2024) Vol. 3, Iss. 4, pp. 241-245
Open Access
